ClinicalTrials.gg
CompletedNCT03064659Updated May 23, 2017

Driving Pressure And EFL in Adult Cardiac Surgery

An observational study in Respiratory Failure, Pneumothorax and Atelectasis, sponsored by Ospedale San Raffaele. Completed at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-05-23.

Sponsored by Ospedale San Raffaele · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

During general anesthesia, functional residual capacity (FRC) is reduced. If the FRC is lower than the minimum volume required to maintain the opening of the airways, there is a derecruitment of the lung parenchyma, leading to the phenomenon of expiratory flow limitation (EFL).

The Driving Pressure (DP) is the difference between the plateau pressure (Pplateau) and the Positive End-Expiratory Pressure (PEEP), and estimates the lung strain.

The incidence of EFL and the importance of DP are not known in adult cardiac surgery, so it's necessary a study to assess both. The primary end-point of the study is to evaluate the correlation of DP and EFL with PPCs in adult cardiac surgery. The secondary end-point of the study is to evaluate: the mechanical ventilation time, the length of ICU and hospital stay, the rehospitalization and mortality.

It will be a prospective, observational, non-pharmacological study. It will enroll 200 patients undergoing elective adult cardiac surgery.

Read the detailed description

During general anesthesia, functional residual capacity (FRC) is reduced. If the FRC is lower than the minimum volume required to maintain the opening of the airways (closing capacity), there is a derecruitment of the lung parenchyma, leading to the phenomenon of expiratory flow limitation (EFL). Numerous factors contribute to the EFL, including hyperoxia, muscle paralysis, the increase of the volume of the interstitial fluids and the inflammatory response.

To establish the presence of EFL under general anesthesia, it was developed a test known as PEEP test. It is the sudden removal of 3 cm H2O to the value of positive end-expiratory pressure (PEEP test): in the EFL the subtraction of the expiratory pressure does not produce an increase of expiratory flow. The use of different modality of mechanical ventilation during cardiac surgery may impact on the incidence of EFL post CEC.

The Driving Pressure (DP) is the difference between the plateau pressure (Pplateau) and the Positive End-Expiratory Pressure (PEEP), and estimates the lung strain.

The primary end-point of the study will be:

  • Evaluate the correlation of DP and EFL with PPCs in patients undergoing elective cardiac surgery performed with extracorporeal circulation.

The secondary end-point of the study will be:

  • Consider whether there are factors associated with the development of EFL, especially comorbidities and ventilation mode during surgery;
  • Evaluate outcomes such as duration of mechanical ventilation, length of stay in intensive care (ICU), PaO2/ FiO2 at discharge from the ICU, development of respiratory complications, duration of hospital stay and mortality.

It will be a prospective, observational, non-pharmacological study. It will enroll 200 patients undergoing elective adult cardiac surgery.

Respiratory rate will be set to maintain PaCO2 at values close to eucapnia. It will be used to pressure-controlled ventilation (Pinsp ≤ 35 cm H2O) only if the controlled ventilation is reached and exceed the maximum airway pressures. In this case it will be necessary to check that the volume delivered by the ventilator is really, for the entire period, the chosen volume. The inspiratory way will be composed of O2, air and maybe the halogenated anesthetic. The O2 concentration will be increased gradually in case of desaturation up to maintain SpO2 93-95% trying not to exceed the FiO2 of 0.8 if it will be choice a protective ventilation strategy.

Weaning from the CEC will include a single alveolar recruitment maneuver, in which the airway pressure will be increased to 40 cm H20 for 7 seconds.

At the end the patients will be transferred to the Intensive Care Unit (ICU) for post-operative monitoring. During the transfer will be supported with mechanical ventilation performed manually by the anesthetist resuscitator.

Extubation in ICU will run in according to the protocol of the center. It could be used any postoperative analgesia that provides NRS at rest ≤ 3 and dynamic NRS (cough) ≤ 4 and allow an active chest physical therapy (CPT).

The following information will be collected:

In the section devoted to the preoperative treats will be fit the patient data related to:

  • Age, weight, height, sex;
  • Comorbidities
  • Positive respiratory history of: previous pleural-parenchymal disease within 30 days prior to the intervention, previous surgery of the thorax, pleura or lung, presence of pleural effusion;
  • History of smoking cigarettes: Active smoking (number of cigarettes), ex-smoker or non-smoker;
  • SpO2, PaO 2, PaO 2 / FiO 2, PaCo 2 (if available);
  • Cardiological history (echocardiography, ECG, etc.)
  • Other medical history information of relevance to the study

In the dedicated intraoperatory tab will be collected the following data:

  • Incidence of EFL and respiratory mechanics parameters;
  • Type of surgery;
  • Time to CEC, clamping, cardioplegia, type of circuit and oxygenator;
  • Transfusion of blood products;
  • Any administration of cardio / vasoactive drugs;
  • Duration of surgery;
  • Other information relevant for the purposes of the study.

In the schedule about the post-operative treats will be collected the following data:

  • Postoperative mechanical ventilation time;
  • Postoperative respiratory complications;
  • Postoperative non-respiratory complications (cardiovascular, infectious, kidney, surgical);
  • The need for re-intubation in the postoperative period;
  • The need for ventilatory support (non-invasive ventilation, invasive ventilation) in the postoperative period;
  • Need for hospitalization in intensive care (expected, unexpected, cause of hospitalization, length of stay);
  • Length of hospital stay;
  • Other information about the postoperative relevant to the study The study does not interfere with the normal anesthetic activity, it does not provide for variations from the procedures currently used and the PEEP test use does not involve pathophysiological changes for the patient.

Data will be collected on the appropriate Case Report Form (CRF). It will be collected anamnestic information, data about surgery and post-operative clinical data, in particular respiratory parameters. Definitions and use of outcome measures are in according to the standards for European Perioperative Clinical Outcome (EPCO) definitions [Eur J Anaesthesiol 2015; 32:88-105].

Data will be analyzed with a professional statistical software. Univariate and multivariate analysis will be performed. Chi-square test will be used for dichotomous variables, z-test/t-test or the Mann-Whitney U-test for continuous variables, as appropriate. Statistical significance if p \<0.05.

02

Conditions studied

  • Respiratory Failure
  • Pneumothorax
  • Atelectasis
  • Respiratory Infection
  • Bronchospasm
  • Pleural Effusion

Keywords

  • Postoperative pulmonary complications
  • Driving Pressure
  • Limitation of Expiratory Flow
  • Cardiac Surgery
  • Cardio-pulmonary bypass
03

In context

Respiratory Insufficiency

1,369 studies on the registry are indexed under Respiratory Insufficiency; 264 are open to participants now.

This study's enrollment of 200 is above the median of 100 across 455 observational studies indexed under Respiratory Insufficiency.

Browse Respiratory Insufficiency studies →

Lead sponsor

Ospedale San Raffaele is the lead sponsor of 46 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

Adult Undergoing Elective Cardiac Surgery

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age > 18 years old
  • Ability to provide an
  • Planned cardiac surgery with median sternotomy and bi-pulmonary ventilation
  • patients scheduled for adult elective cardiac surgery, performed with CPB and aortic cross-clamping.

Exclusion criteria

Exclusion Criteria:

  • Patient refusal to provide
  • Emergency surgery
  • Cardiac surgery with TAVI/MitraClip
  • Planned thoracotomy with one lung ventilation
  • Patients with chronic kidney insufficiency (defined as dialysis)
  • Patients already intubated in the peri-operative period
  • Patients with pneumonia in the pre-operative period (30 days before surgery)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (actual)
Target follow-up
1 Month
Patient registry
Yes
06

What researchers measure

Primary outcomes

  1. Expiratory Flow Limitation

    Time frame: Through study completion, an average of 24 hours after surgery

  2. Incidence of Driving Pressure

    Time frame: Through study completion, an average of 24 hours after surgery

Secondary outcomes

  1. Postoperative pulmonary complication

    Respiratory Failure, Pneumothorax, Atelectasis, Respiratory Infection, Bronchospasm, Pleural Effusion

    Time frame: Through study completion, an average of 7 days after surgery

  2. ICU length of stay

    Time frame: Through study completion, an average of 24 hours after surgery

  3. Hospital length of stay

    Time frame: Through study completion, an average of 7 days after surgery

  4. Duration of mechanical ventilation

    Time frame: Through study completion, an average of 7 days after surgery

  5. PaO2/ FiO2

    Time frame: Through study completion, an average of 24 hours after surgery

  6. Mortality

    Time frame: Through study completion, an average of 7 days after surgery

07

Study locations

1 site
  • Ospedale San Raffaele
    Milano, MI 20132, Italy
08

References and documents

Publications

  • Grieco DL, Chen L, Dres M, Brochard L. Should we use driving pressure to set tidal volume? Curr Opin Crit Care. 2017 Feb;23(1):38-44. doi: 10.1097/MCC.0000000000000377. PubMed 27875410 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 23, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03064659
Lead sponsor
Ospedale San Raffaele
Responsible party
Elena Bignami (MD, Ospedale San Raffaele) — Principal investigator
First posted
Feb 27, 2017
Start date
Nov 2015
Primary completion
Jan 2017
Completion
May 2017
Last update
May 23, 2017

Study contacts

Elena Bignami, MD
principal investigator · Ospedale San Raffaele

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion